Research progress on the role of gut microbiota dysbiosis in the pathogenesis of immune-mediated liver diseases.

Anti-MRPS27 Antibody: A Novel Diagnostic Biomarker for Autoimmune Hepatitis Identified via a Human Proteome Microarray.

Meta-Analysis: PPAR Agonists for Pruritus and Quality of Life in Primary Biliary Cholangitis.

Geographic distribution and demographic patterns of primary biliary cholangitis and autoimmune hepatitis in Colombia: a national population-based administrative study (2018-2024).

Consensus statements of the Hellenic Autoimmune Liver Diseases Study Group on the diagnosis and current management of primary biliary cholangitis.

Zoledronic acid improves bone mineral density at the lumbar spine and total hip in adults with chronic liver disease.

Primary Biliary Cholangitis and Prognostic Models-Reply.

Primary Biliary Cholangitis and Prognostic Models.

Letter: The association between liver biochemistry, biliary and fibrosis in primary biliary cholangitis.

Primary Biliary Cholangitis Increases Mortality Irrespective of Presence or Absence of Cirrhosis.

Probiotic Lactobacillus rhamnosus mitigates PBC-like features in Mcpip1-deficient mice via modulation of gut-liver crosstalk.

Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis.

[Bullous pemphigoid and primary biliary cholangitis, a rare association with therapeutic challenge].

Liver transplant outcomes in primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease overlap.

Conjugated bile acids facilitate cholangiocyte senescence to promote cholestatic liver diseases via STING signaling.

Mast Cells at the Crossroad of Gut-Derived Signals Through Aryl Hydrocarbon Receptor Activation: A Microbial-Immune Dialogue in Liver Inflammation with Therapeutic Perspectives.

Risk factors for mortality in patients with primary biliary cholangitis: a nomogram to predict 5-year survival.

Integrative Mendelian randomization and experimental validation unveil novel druggable targets in primary biliary cholangitis.

Metabolic syndrome and its individual components but not MASLD are associated with advanced fibrosis in primary biliary cholangitis.

Constructing a protein-protein interaction network for autoimmune liver diseases by integrating pQTL, rQTL, and mediation analyses.

Optimising Primary thErapy in pRimAry biliary cholangitis (OPERA): protocol for a randomised, double-blind, placebo-controlled trial of enhanced primary therapy with obeticholic acid.

Dual cut-offs and beyond: Expanding the role of transient elastography in primary biliary cholangitis.

Fatigue and circadian rhythm in non-cirrhotic primary biliary cholangitis: An exploratory comparison with primary sclerosing cholangitis and healthy controls.

Adipokine profiles reflect metabolic dysfunction but not fibrosis in patients with primary biliary cholangitis.

High-intensity hydrophilic versus lipophilic statins in patients with primary biliary cholangitis: a multi-institutional analysis.

Can liver biopsy be spared for the diagnosis of autoimmune hepatitis in selected children? A multicenter retrospective study.

[Positive antinuclear antibodies suggest a high inflammatory burden phenotype: a multicenter retrospective analysis of patients with primary biliary cholangitis].

The PBC Ireland patient registry: study protocol for a national platform on primary biliary cholangitis.

Australian best practice recommendations for transjugular intrahepatic portosystemic shunt (TIPS) in portal hypertension: a consensus statement.

Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis.

Pyroptosis Plays a Key Role Through Macrophages in Primary Biliary Cholangitis of Mice.

Reconciling the role of ileal bile acid transporter inhibitors as symptom-directed therapy in primary biliary cholangitis: a focused meta-analysis.

Somatostatin Effect on Growth Factors in Hepatocellular Carcinoma.

How do oral pathogenic bacteria potentially contribute to inflammatory processes in autoimmune liver disease? Results from a systematic review.

Visualization analysis of the use of traditional Chinese medicine in the diagnosis and treatment of rare diseases in mainland China based on CiteSpace.

Comments on: Pre-Diagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis.

The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view.

Mechanistic Rationale of Seladelpar's Clinical Efficacy through the Selective PPAR-δ Activation in Primary Biliary Cholangitis.

Stains in primary biliary cholangitis: Untangling promise from bias.

Rheumatologic Manifestations of Patients With Type B Insulin Resistance.

Long-Term Use of Fenofibrate as Second-Line Therapy in Primary Biliary Cholangitis: A Retrospective Study.

Human leukocyte antigen variants and clinical features of primary biliary cholangitis: Cumulative contributions.

Cost of hepatic decompensation and liver transplantation events in primary biliary cholangitis: a retrospective observational study.

Plasma Biomarkers of Senescence in Cholestatic Liver Disease: A Signature of Risk Stratification and Progression.

Mesenchymal stromal cell administration promotes macrophage-mediated bile duct regeneration.

Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review.

A Review on Farnesoid X Receptor (FXR) Modulators Focusing on Benzimidazole Scaffold.

The Involvement of Apoptosis Inhibitor of Macrophage in the Disease Severity of Primary Biliary Cholangitis.

Primary biliary cholangitis with inflammation involving zone 3 of the liver has a poor response to ursodeoxycholic acid treatment: a retrospective cohort study.

Clinicopathological features of hepatobiliary cells in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid.

Exploration and discovery of treatment targets for primary biliary cholangitis based on plasma and cerebrospinal fluid proteomics: A multicenter mendelian randomization study.

Direct bilirubin was superior to total bilirubin in predicting the long-term outcomes of patients with primary biliary cholangitis.

Evaluation of Histological Criteria and Immunoserological Testing of Simplified Criteria for the Diagnosis of Autoimmune Hepatitis.

Elevated Serum Soluble Tim-3 in Primary Biliary Cholangitis: Lack of Correlation with Cytokines, Chemokines, and Clinical Parameters.

Longitudinal multi-omics pilot study: Small sample size human model of gut microbiota-mitochondrial metabolic dysregulation in primary biliary cholangitis.

Primary Biliary Cholangitis-associated Osteoporosis: Contemporary Review of Pathogenesis and Management.

Acute Graft-Versus-Host Disease After Deceased-Donor Liver Transplantation: A Case Report.

A multifaceted analysis of OTUD5 integrated MAVS in innate immunity of Primary Biliary Cholangitis.

Association between type 2 diabetes and autoimmune liver disease: An integrated analysis of Mendelian randomization and clinical samples.

Ileal Bile Acid Transporter Inhibitors in Cholestasis: Potential for More Than Just Paediatrics?

Autoimmune hepatitis overlap syndrome: Clinical presentation, treatment response, and disease evolution: Tertiary centre experience.

Lipidome remodeling in primary biliary cholangitis.

Use of Ursodeoxycholic Acid and Cancer Risk for Patients With Primary Biliary Cholangitis.

Association between statin use and hepatic decompensation in patients with primary biliary cholangitis: A target trial emulation study.

Primary Biliary Cholangitis: Novel and Emerging Therapies.

Exploring Current and Emerging Therapies for Patients With Primary Biliary Cholangitis.

Diagnostic potential of salivary biomarkers for primary biliary cholangitis: a systematic review.

Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases-A Cross-Sectional Multicentre Study.

Alkaline Phosphatase Normalization Occurs Less Frequently in Hispanic Patients With Primary Biliary Cholangitis.

IGFBP4 is a Metric for Primary Biliary Cholangitis and Attenuates Biliary Epithelial Cell Injury.

Bile acids as therapeutic agents.

Awareness of Primary Biliary Cholangitis Among Turkish Physicians: A Cross-Sectional, Multicenter, Web-Based Survey.

Identification of Differentially Expressed Genes and Molecular Pathways Involved in Primary Biliary Cholangitis Using RNA-Seq.

Elevated Epithelial Splicing Regulatory Protein 1 Expression in Biliary Atresia Indicates Its Potential as a Molecular Marker.

Kupffer cell autophagy emerges as a central regulator of immune dysregulation in primary biliary cholangitis.

Seladelpar Improves Cholestasis and Pruritus in Obeticholic Acid and Fibrate-experienced Patients With Primary Biliary Cholangitis.

Organ-specific autoimmunity in primary Sjögren's disease.

The role of gut microbiota in the pathogenesis of primary biliary cholangitis: an immunological perspective.

Metabolic Dysfunction-Associated Steatohepatitis With Positive Antimitochondrial M2 Antibodies: Diagnostic Pitfall and Importance of Follow-Up.

Higher sun exposure is associated with a reduced risk of primary biliary cholangitis.

ATF3 Mediates the Immunoregulatory Role of the Tim-3 Pathway in Primary Biliary Cholangitis.

Factors associated with recompensation and criteria for etiological suppression in patients with primary biliary cholangitis.

FCRL3 as a potential link between Benzo[a]pyrene exposure and primary biliary cholangitis: insights from comparative toxicogenomics and multi-omics analysis.

Impact of Type 2 Diabetes Mellitus on Liver Fibrosis and Hepatic Steatosis in Patients with Primary Biliary Cholangitis: A Longitudinal Study.

Dysgeusia-Driven Nutritional Decline in Cirrhosis: A Case of Autoimmune Hepatitis and Primary Biliary Cholangitis.

Inferior Vena Cava-Atrial Anastomosis in Liver Transplant Recipient with Inferior Vena Cava Occlusion: A Case Report and Literature Review.

Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to Therapy.

Evaluating the clinical care, quality of life and overall experiences of patients with primary biliary cholangitis (PBC) during the pandemic: A Canadian mixed-methods study.

[A case of recurrent hypoglycemic coma episodes associated with primary biliary cholangitis and literature review].

Genetic evidence supports primary biliary cholangitis as a risk factor for lacunar stroke.

Variation in microbiome and metabolites is associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus.

Anti-mitochondrial M2 antibody links to cardiac involvement and immune-mediated inflammatory myopathy-like pathology in myositis.

Cell-specific epigenome-wide DNA methylation in peripheral CD4(+) lymphocytes from patients with primary biliary cholangitis.

Primary Biliary Cholangitis With Incomplete Response to Conventional Therapies But Had Complete Response to Baricitinib: A Case Report.

Decoding the Gut Microbiome in Primary Sjögren's Syndrome and Primary Biliary Cholangitis: Shared Dysbiosis, Distinct Patterns, and Associations with Clinical Features.

Liver Innervation in Health and Disease: Neuroimmune-Neurovascular Interface and Future Therapeutic Implications.

Clinical characteristics and factors associated with liver stiffness in patients with autoimmune liver disease: a cross-sectional study from the Kashgar region.

The Personalized Management of Primary Biliary Cholangitis in the Era of Precision Medicine: Current Challenges and Future Perspectives.

Gastric Squamous Cell Carcinoma as a Cause of Clinically Unstable Gastrointestinal Bleeding.

Vitamin D3 attenuates hepatic inflammation in primary biliary cholangitis by inhibiting TLR4/NF-κB mediated M1 macrophage polarization.

PBC-AIH variant syndrome: emerging new terminology and a new approach to diagnosis and management.

The causal relationship between inflammatory bowel disease and primary biliary cholangitis: A bidirectional two-sample Mendelian randomization study.

Autoimmune thyroid disease and human health: a systematic review of Mendelian randomization studies.

Systemic inflammatory response index: a novel predictor for cardiovascular disease risk in patients with primary biliary cholangitis.

Clinical outcomes and early- prognostic biomarkers of primary biliary cholangitis with ductopenia.

Association between quality of life and inflammation and fibrosis markers in primary biliary cholangitis over three-year follow-up.

Pleiotropic gene mapping reveals shared immune regulatory hubs across 15 autoimmune diseases.

Mechanistic roles and therapeutic potential of bacteriophages in inflammatory gastrointestinal diseases.

Ubiquitin D Correlates with Disease Severity and T Cell Infiltration in Cholestasis: Evidence from Integrated Bioinformatics and Experimental Analyses.

Primary biliary cholangitis (PBC): evolving approaches and expert perspectives.

Assessing the concordance between centromere AC-3 immunofluorescence pattern and anti-centromere protein-B antibody, and analyzing clinical correlates of dual positivity: A retrospective study.

Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome with primary biliary cholangitis and alcoholic liver disease: a case report.

Autoimmune liver diseases in Latin America: Current landscape and challenges.

A novel cell-permeable LOXL2 inhibitor PAT-1251 potently suppresses biliary liver fibrosis via collagen crosslinking-dependent and -independent mechanisms.

Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study.

Randomized Controlled Trial Evidence on Peroxisome Proliferator-Activated Receptor (PPAR) Agonists in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets.

From Isolation to Information: Launching an Online Community for Patients with Primary Sclerosing Cholangitis, Primary Biliary Cholangitis, and Autoimmune Hepatitis in Romania-A Descriptive Study.

Autophagy of Kupffer cells modulates CD8+ T cell activation in primary biliary cholangitis.

Necrotizing Fasciitis Caused by Serotype 7C Streptococcus pneumoniae in Overwhelming Post-splenectomy Infection.

Beyond bones: Revisiting the role of vitamin D in chronic liver disease.

Unveiling the Spectrum of Liver Endurance in Systemic Lupus Erythematosus: A Single-Center Experience From Kashmir, India.

Clinical characteristics of newly diagnosed patients with primary biliary cholangitis (PBC) indicate the need for better awareness on timely diagnosis and adequate UDCA therapy.

Association between elevations in alkaline phosphatase and healthcare utilization and costs among individuals with primary biliary cholangitis in the United States.

Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.

Diagnostic Pitfalls in Primary Biliary Cholangitis: Delta Bilirubin and Lipoprotein-X Interferences.

Quantitative detection of anti-centromere antibodies in primary biliary cholangitis: value of chemiluminescence immunoassay.

Tumor necrosis factor alpha-induced protein 3: Biomarker discovery and therapeutic advancement in primary biliary cholangitis.

Risk factors for autoimmune liver disease recurrence after liver transplantation.

Triple autoimmune overlap syndrome of the liver: a rare case of concomitant PBC, PSC, and AIH.

Bile Acid Metabolites Control Th17/Treg Balance in Primary Biliary Cholangitis: Mechanisms of Disease Progression and Therapeutic Targets.

Economic Burden of Primary Biliary Cholangitis by Line of Therapy in the United States.

Smoking and liver diseases: an updated review of pathogenesis, progression, and therapeutic implications.

Association between ABO blood group system and autoimmune liver disease.

Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes.

Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025.

Fracture events in patients with primary biliary cholangitis during treatment with seladelpar in the phase III RESPONSE trial.

Mendelian randomization study of the causal relationship between autoimmune diseases and anemia using proteomic and genetic data.

AMA-Negative Primary Biliary Cholangitis and Autoimmune Hepatitis Overlap Syndrome Presenting With Bullous Pemphigoid: A Case Report.

Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation.

Golexanolone Attenuates Neuroinflammation, Fatigue, and Cognitive and Motor Impairment in Diverse Neuroinflammatory Disorders.

Profile of Patients with Primary Biliary Cholangitis and Evaluation of Response to Ursodeoxycholic Acid in a Romanian Center-Retrospective Study.

Proteomics identifies complement protein signatures in patients with primary biliary cholangitis.

Systemic PCSK9 elevation characterises autoimmune liver disease across sexes.

Optimizing Care in Primary Biliary Cholangitis: Current Treatments and the Second-Line Decision.

Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis.

Primary biliary cholangitis. Treatment options in 2025. A narrative review.

Lipoprotein X-Induced Hyperlipidemia Following Liver Transplantation in the Setting of Persistent Cholestasis and Antibody-Mediated Rejection.

Exploring Maralixibat for Treatment-Resistant Pruritus in Intrahepatic Cholestasis of Pregnancy and Primary Biliary Cholangitis: A Case Report.

Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database.

What the European Reference Network Registry for Rare Liver Diseases Tells Us About Primary Biliary Cholangitis in European Practice.

The risk and prevalence of hepatic diseases in psoriasis: A systematic review and meta-analysis.

Case Report: Novel IRF2BP2 variant in a Japanese patient with impaired B-cell differentiation, Th1 polarization, and systemic immune dysregulation.

HSC-derived exosomal miR-122-5p inhibits EMT and fibrosis of intrahepatic biliary epithelial cells to alleviate primary biliary cholangitis.

Simultaneous degenerative changes in 2 hepatic cavernous hemangiomas observed over 23 years of follow-up: A case report and review of the literature.

Hepatocyte iron suppresses liver fibrosis via fibrolytic neutrophil recruitment in cholestasis.

Numb-exon3 and full length Numb equivalently alleviate cholestatic liver fibrosis by inhibiting ductular reaction.

Optimizing clinic consultations in primary biliary cholangitis: International consensus recommendations.

Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP.

PPARevolution. First PPARδ Agonist and a Dual PPARα/PPARδ Activator Approved for the Treatment of Primary Biliary Cholangitis.

Tepotinib-Induced Cholangitis in a Patient With Non-Small Cell Lung Cancer: A Case Report.

Letter on 'Non-Response to Obeticholic Acid Is Associated With Heightened Risks of Developing Clinical Events in Primary Biliary Cholangitis'.

Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study.

Progress and prospects of gut microbiota-targeted therapy for primary biliary cholangitis.

Primary Biliary Cholangitis.

Percutaneous Transvenous Retrograde Embolization of Adhesion-Related Small Bowel Varices: A Case Report.

Beyond Ursodeoxycholic Acid: A Comprehensive Review of Second-Line Agents in Primary Biliary Cholangitis.

FXR-targeted drug discovery: Recent advances and therapeutic perspectives.

Reevaluating the clinical course of AMA-positive patients with normal liver enzymes: A large retrospective cohort study.

Treatment of Refractory Pruritic Dermatitis in the Setting of Primary Biliary Cholangitis and CREST Syndrome With Upadacitinib.

Microbiome and gut-liver interactions: From mechanisms to therapies.

Single-Nuclei RNA Sequencing Shows the Engagement of PPAR-Delta Target Genes Primarily in Hepatocytes and Cholangiocytes by the Selective PPAR-Delta Agonist Seladelpar.

Letter: Optimizing Risk Stratification in Primary Biliary Cholangitis-The Role of Biochemical Response as a Dynamic Predictor.

Linerixibat in patients with primary biliary cholangitis and cholestatic pruritus (GLISTEN): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.

Ileal bile acid transporter inhibitors for cholestatic pruritus in primary biliary cholangitis.

Treatment Persistence, Normal Alkaline Phosphatase and Clinical Outcomes in Primary Biliary Cholangitis.

Research Communication: Real-World Clinical Experience With Seladelpar in Primary Biliary Cholangitis.

Macrophages in Autoimmune Liver Diseases: From Immune Homeostasis to Precision-Targeted Therapy.

Second-Line Therapies in Primary Biliary Cholangitis: A Comparative Review of Obeticholic Acid, Fibrates, Seladelpar, and Elafibranor.

Noninvasive elastography-based assessment of liver fibrosis in primary biliary cholangitis.

The Genomics/Genetics of Primary Biliary Cholangitis: The Case for a Functional SNP rs10893900 in ETS1/FLI1 and Review of the Literature.

Multi-omics profiling uncovers paradoxical Epstein-Barr virus involvement in autoimmune liver disease pathogenesis.

Autophagy Sustained the Activation and Survival of Liver-infiltrating CD8+ T Cells in Primary Biliary Cholangitis.

The role of mitochondria-related key genes in primary biliary cholangitis was analyzed based on transcriptome sequencing data.

Identification of galangin as a therapeutic candidate for primary biliary cholangitis via systematic druggable genome-wide Mendelian randomization analysis and experimental validation.

Recurrent primary biliary cholangitis after liver transplantation: A global meta-analysis of epidemiology and risk factors.

Histological characteristics of primary biliary cholangitis in patients with incomplete responses to ursodeoxycholic acid.

Assessment of adherence to guidelines for biochemical monitoring and ursodeoxycholic acid treatment response in a retrospective cohort of US patients with primary biliary cholangitis.

Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER).

Mixed Multiple Autoimmune Syndrome Type 3 With Coexistence of Primary Biliary Cholangitis, Inflammatory Myopathy, and Chronic Thyroiditis: A Case Report.

Advancing the management of primary biliary cholangitis: From pathogenesis to emerging therapies.

Innate immunity of bile and cholangiocytes in primary biliary cholangitis.

Future Treatment Options for Managing Primary Sclerosing Cholangitis and Cholestatic Pruritus.

Recent Advances in Primary Biliary Cholangitis Treatment.

Causes, associated exposures, and outcomes of cirrhosis and hepatocellular carcinoma in Malawi: an observational cohort and case-control study.

The effects of lifestyle factors on primary biliary cholangitis ascertained by two-sample Mendelian randomization.